Hydrogen in Biomedicine
Molecular hydrogen might be the next big thing in biomedicine, with over 300 studies published in the past decade suggesting beneficial effects of this novel agent. However, collecting and interpreting unbiased data using evidence-based approach is a must to provide the best guidelines in making decisions about the use of hydrogen in health and disease.
Professor Sergej M. Ostojic, MD, PhD
Studies in Numbers
In recent years, we published several papers about molecular hydrogen in well respected peer-reviewed journals, focused to H2 bioactivity and its use in cardiometabolic disorders.
Donate to Hydrogen Medicine Initiative
There are several ways of supporting our activities, besides reading and spreading evidence-based information from this portal. You can also donate funds that will enable us to continue our research that addreses different aspects of hydrogen application in biomedicine.
Hydrogen inhalation improves outcomes in asphyxia induced-cardiac arrestOctober 22, 2020
Hydrogen inhalation during EVLP improved donation after cardiac deathOctober 15, 2020
Hydrogen ameliorates chronic neurocognitive impairmentOctober 8, 2020
Hydrogen improves neurological outcomes in cardiac arrestOctober 3, 2020
A preventive and therapeutic medical gas
Since the 2007 discovery that H2 has selective antioxidant properties, multiple studies have shown that H2 has beneficial effects in diverse animal models and human diseases.
Read More from Open Acces 2017 Oncotarget paper →
This portal is an independent division of the Center for Health, Exercise and Sport Sciences (CHESS) web structure, established to present scientific studies on biomedical use of molecular hydrogen, and to promote institutional research intitatives in hydrogen research. All entries are collected from peer-reviewed academic journals and publications, and pertinent scientific events. Our mission is to collect an unbiased data and provide current best evidence in making decisions about the use of molecular hydrogen in health and disease.